(Q46959461)

26 December 2017

title

Genomics-based drug design targets the AT-rich malaria parasite: implications for antiparasite chemotherapy (English)

1 reference

26 December 2017

0 references

1 reference

4

1 reference

26 December 2017

author name string

Stephanie K Yanow

series ordinal

1

1 reference

26 December 2017

Lisa A Purcell

series ordinal

2

1 reference

26 December 2017

Moses Lee

series ordinal

3

1 reference

26 December 2017

publication date

1 September 2007

1 reference

26 December 2017

published in

Pharmacogenomics

1 reference

26 December 2017

volume

8

1 reference

26 December 2017

issue

9

1 reference

26 December 2017

page(s)

1267-1272

1 reference

26 December 2017

Pharmacogenomic analyses of targeting the AT-rich malaria parasite genome with AT-specific alkylating drugs

cites work

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Antimalarial drug discovery: efficacy models for compound screening

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Genome sequence of the human malaria parasite Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

The A/T-specific DNA alkylating agent adozelesin inhibits Plasmodium falciparum growth in vitro and protects mice against Plasmodium chabaudi adami infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

DNA base excision repair in human malaria parasites is predominantly by a long-patch pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Defective DNA repair as a potential mechanism for the rapid development of drug resistance in Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

DNA minor groove binders as potential antitumor and antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Phase I trial of Adozelesin using the treatment schedule of daily x5 every 3 weeks

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Dicationic biphenyl benzimidazole derivatives as antiprotozoal agents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Pharmacokinetics and metabolism of the prodrug DB289 (2,5-bis[4-(N-methoxyamidino)phenyl]furan monomaleate) in rat and monkey and its conversion to the antiprotozoal/antifungal drug DB75 (2,5-bis(4-guanylphenyl)furan dihydrochloride).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Efficacy of DB289 in Thai patients with Plasmodium vivax or acute, uncomplicated Plasmodium falciparum infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Complete Genome Sequence of the Apicomplexan, Cryptosporidium parvum

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Genome Sequence of Theileria parva, a Bovine Pathogen That Transforms Lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

A genome sequence survey of the filarial nematode Brugia malayi: repeats, gene discovery, and comparative genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Genome sequence and comparative analysis of the model rodent malaria parasite Plasmodium yoelii yoelii

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Genomics of parasitic flatworms

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

A phase I study of bizelesin, a highly potent and selective DNA-interactive agent, in patients with advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Medicines for Malaria Venture: sustaining antimalarial drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Selective toxicity to malaria parasites by non-intercalating DNA-binding ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Antimalarial activity of synthetic analogues of distamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

Synthesis and antiparasitic evaluation of bis-2,5-[4-guanidinophenyl]thiophenes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14622416.8.9.1267

10.2217/14622416.8.9.1267

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017